• Hector Fellows

    Distinguished researchers in STEM fields.

Prof. Dr. Dr. h.c. mult. Eberhart Zrenner

Institute for Ophthalmic Research of the University Hospital, Eberhard Karls Universität Tübingen

Hector Fellow since 2012

Eberhart Zrenner is Senior Professor of Ophthalmology at the Werner Reichardt Centre for Integrative Neuroscience and Founding Director of the Institute for Ophthalmic Research of the University of Tübingen.

He is an internationally recognized specialist for degenerative diseases of the retina, especially in the field of cause research and therapy development. He has been particularly involved in the development of electronic subretinal retinal implants to restore vision in the blind. He is also significantly involved in the development and implementation of the world's first ocular gene replacement therapy for color blindness and the first gene therapy developments in Germany for hereditary retinal degenerations.

For his work, he was granted the Ludwig von Sallmann Prize und den Karl Heinz Beckurts Prize. He is a member of the German National Academy of Sciences (Leopoldina) and the Heidelberg Academy of Sciences and Humanities. He was speaker of the SFB 430, until 2005 senator and until 2020 member of the Board of Trustees of the Max Planck Society, until 2009 member of the Science Council and the Health Research Council.

Research fields

  • Degenerative diseases of the retina
  • Ocular toxicology and clinical electrophysiology
  • Optoelectronical retinal implants
  • Gene replacement therapy


Enable Blind People to see again - Retinal Implants with integrated microelectrodes make it possible

Eberhart Zrenner and his team are developing novel micro-electrodes based on high-tech materials for the spatial and temporal high-resolution electrical stimulation of neuronal tissue. In the therapy of patients suffering from hereditary retinal degeneration, these will contribute to an even clearer improvement in visual performance.

See here in the short film "Enable blind people to see again" what relevance Zrenner's research has for the cooperation between medicine and technology as well as the therapy of patients suffering from hereditary retinal degeneration.